Physicians' Academy for Cardiovascular Education

RAS Blockade in the Real World: From Clinical Trial Data to Challenges in Daily Hypertension Management

3' education - Oct. 28, 2011

RAS Blockade in the Real World:
From Clinical Trial Data to Challenges in Daily Hypertension Management


Prof. Sverre Kjeldsen
, University of Oslo, Norway,  discusses the implementation of clinical trial results into daily practice in the field of hypertension.

The key educational objectives to be addressed in this expert commentary are:
  • The REAL Life study in hypertension
  • Results in heart failure patients
  • The contribution of ARBs in hypertension management
  • ARB's and cancer: associated or not?




About the speaker

Sverre E. Kjeldsen, is Professor and Chief Physician at the Department of Cardiology, Ullevaal University Hospital,
Oslo, Norway and Adjunct Professor of Medicine at the Division of Cardiovascular Medicine, University of
Michigan, Ann Arbor, Michigan, USA.
His main research interest is the pathophysiology, epidemiology and treatment of human hypertension with
more than 250 full peer-reviewed original articles published. He has served as executive or steering committee
member on several large clinical outcome trials in hypertension (HOT, NO RDIL, INSIGHT, LIFE, VALUE, ASCOT,
ACCOMPLISH, SCAST).
Professor Kjeldsen was President of the European Society of Hypertension 2005-2007, he is a fellow the American
Heart Association - the Council for High Blood Pressure Research, and he is a member of the ESH-ESC 2003 and
2007 Hypertension Guidelines Committees.
Professor Kjeldsen received his medical degree from the University of Oslo in 1979, his PhD degree from the
University of Oslo, 1984, and he was a medical resident and fellow in Cardiology at Ullevaal University Hospital
and Assistant Professor at University of Michigan 1987-89.

Share this page with your colleagues and friends: